The global baby diaper rash cream market size reached US$ 1.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.2 Billion by 2028, exhibiting a growth rate (CAGR) of 6.87% during 2023-2028.
A diaper rash, medically known as diaper dermatitis, causes skin irritation due to chemical allergies, prolonged wetness, bacterial infection and diaper friction. It can also alter the sleeping pattern of the infant/baby, reduce the frequency of urination or defecation, and lead to severe skin inflammation. At present, there is an increase in the demand for the baby diaper rash cream as it helps in calming these symptoms and preventing them from reoccurring by forming a protective barrier between the baby’s skin and potential irritants. It is generally manufactured using beeswax, zinc oxide, mineral oil and skin soothers.
Due to the increasing consciousness among parents about the harmful impact of utilizing baby products in the long term, there has been a gradual shift toward natural products that are free from parabens, phthalates, silicones, petrochemicals, artificial preservatives and other synthetic additives. In line with this, they are also investing in organic products, which are produced using ingredients such as sunflower seed, jojoba, almond and calendula oils. These organic variants offer antifungal and antibacterial qualities as well as aid in reconditioning and softening the baby’s skin. Furthermore, some of the leading manufacturers operating in the industry are investing in promotional campaigns to retain a competitive edge and expand their existing consumer base. Additionally, the proliferation of supermarkets and hypermarkets, in confluence with the burgeoning e-commerce sector, is anticipated to increase product accessibility, particularly in the developing economies.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global baby diaper rash cream market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on gender, type and distribution channel.
Breakup by Gender:
The male segment currently exhibits a clear dominance in the market.
Breakup by Type:
Zinc Oxide Free
At present, zinc oxide-based creams represent the most commonly utilized product as they help in forming a protective layer around rashes.
Breakup by Distribution Channel:
Supermarkets and Hypermarkets
Supermarkets and hypermarkets account for the majority of the total market share as they offer a one-stop-shop experience to buyers.
Middle East and Africa
United Arab Emirates
On the geographical front, Asia Pacific enjoys the leading position in the market due to various product launches in the region.
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are:
Bepanthen (Bayer AG)
Bio Veda Action Research Co.
Burt's Bees (The Clorox Company)
Chicco USA Inc. (Artsana USA Inc.)
Johnson & Johnson
Mission Pharmacal Company
Sebapharma GmbH & Co. KG
Sudocrem (Teva Pharmaceutical Industries Ltd)
Summers Laboratories Inc.
The Himalaya Drug Company
W.S. Badger Company
Base Year of the Analysis
Gender, Type, Distribution Channel, Region
Asia Pacific, Europe, North America, Latin America, Middle East and Africa
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Turkey, Saudi Arabia, Iran, United Arab Emirates, Brazil, Mexico, Argentina, Colombia, Chile, Peru
Beiersdorf AG, Bepanthen (Bayer AG), Bio Veda Action Research Co., Burt's Bees (The Clorox Company), Cetaphil, Chicco USA Inc. (Artsana USA Inc.), Johnson & Johnson, Mission Pharmacal Company, Mustela, NUK, Sebapharma GmbH & Co. KG, Sudocrem (Teva Pharmaceutical Industries Ltd), Summers Laboratories Inc., The Himalaya Drug Company, W.S. Badger Company and Weleda International
10% Free Customization
Report Price and Purchase Option
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report
The global baby diaper rash cream market was valued at US$ 1.5 Billion in 2022.
We expect the global baby diaper rash cream market to exhibit a CAGR of 6.87% during 2023-2028.
The rising demand for organic baby diaper rash creams using ingredients, such as sunflower seed, jojoba, almond, and calendula oils, along with the introduction of antifungal and antibacterial product variants that aid in reconditioning and softening the baby’s skin, is primarily driving the global baby diaper rash cream market.
The sudden outbreak of the COVID-19 pandemic has led to the changing consumer inclination from conventional brick-and-mortar distribution channels towards online retail platforms for the purchase of baby diaper rash creams.
Based on the gender, the global baby diaper rash cream market can be bifurcated into female and male. Currently, male holds the majority of the total market share.
Based on the type, the global baby diaper rash cream market has been segmented into zinc oxide-based and zinc oxide free, where zinc oxide-based currently exhibits a clear dominance in the market.
Based on the distribution channel, the global baby diaper rash cream market can be divided into supermarkets and hypermarkets, specialist retailers, medical retailers, online stores, and others. Currently, supermarkets and hypermarkets account for the largest market share.
On a regional level, the market has been classified into Europe, North America, Asia Pacific, Middle East and Africa, and Latin America, where Asia Pacific currently dominates the global market.
Some of the major players in the global baby diaper rash cream market include Beiersdorf AG, Bepanthen (Bayer AG), Bio Veda Action Research Co., Burt's Bees (The Clorox Company), Cetaphil, Chicco USA Inc. (Artsana USA Inc.), Johnson & Johnson, Mission Pharmacal Company, Mustela, NUK, Sebapharma GmbH & Co. KG, Sudocrem (Teva Pharmaceutical Industries Ltd), Summers Laboratories Inc., The Himalaya Drug Company, W.S. Badger Company, Weleda International, etc.
Need more help?
Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.